Is Helix BioPharma Corp. HBP stock halal to invest in?

No, as of February 2026, Helix BioPharma Corp. stock (HBP) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Helix BioPharma Corp. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Helix BioPharma Corp. and alternative halal stock options within the Tabadulat app.

How often is Helix BioPharma Corp. HBP reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Helix BioPharma Corp. HBP monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Helix BioPharma Corp. HBP pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Helix BioPharma Corp. stock (HBP) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Helix BioPharma Corp. HBP pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of February 2026, Helix BioPharma Corp. stock (HBP) passes the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments are below the acceptable threshold set by AAOIFI.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, Helix BioPharma Corp. stock (HBP) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Helix BioPharma Corp.

TSX

Shariah-Compliant

Not Shariah

HBP

About

Helix BioPharma Corp.

HBP

Helix BioPharma Corp. is a clinical-stage biopharmaceutical company specializing in oncology, with a primary focus on developing innovative therapies for hard-to-treat cancers including solid tumors and hematological malignancies. Founded in 1995 and headquartered in Toronto, Canada, Helix BioPharma advances novel immuno-oncology treatments based on proprietary technology platforms, notably targeting the CEACAM6 protein overexpressed in various cancers. Its lead candidate, L-DOS47, is an antibody-enzyme conjugate designed to modify the acidic tumor microenvironment, aiming to enhance immune response and the efficacy of existing cancer therapies, specifically in non-small cell lung cancer and pancreatic cancer. The company has expanded its pipeline through strategic acquisitions and collaborations, developing additional candidates like LEUMUNA™ for post-transplant leukemia relapse and GEMCEDA™, an oral gemcitabine prodrug. Helix BioPharma operates globally with listings on multiple exchanges, reflecting its commitment to advancing cancer treatment options through targeted, mechanism-based therapies that address significant unmet medical needs.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

Website:

https://www.helixbiopharma.com

HBP

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Helix BioPharma Corp.

About

Helix BioPharma Corp.

HBP

Frequently asked questions

Is Helix BioPharma Corp. HBP stock halal to invest in?

How often is Helix BioPharma Corp. HBP reviewed for Shariah compliance?

Does Helix BioPharma Corp. HBP pass the AAOIFI Non Permissible Income criteria?

Does Helix BioPharma Corp. HBP pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Helix BioPharma Corp. HBP stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.